Exhibit 23.1

             INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT

We consent to the use in this Registration Statement on Form SB-2, of our report
dated April 12, 2006 with respect to our audit of the  financial  statements  of
China  Biopharmaceuticals  Holdings,  Inc. as of and for the year ended December
31, 2005,  and to the  reference to our firm under the heading  "Experts" in the
Prospectus.

/s/ Moore Stephens Wurth Frazer and Torbet, LLP
Walnut, California
May 25, 2006